MIP Diagnostics
Stephane Argivier currently serves as the Chief Executive Officer of Logical Biological, a company specializing in the sustainable supply of critical material solutions, including biospecimens, aimed at accelerating diagnostic and therapeutic advancements. In addition to this role, Stephane holds the position of Director at Telophase Associates Ltd., providing consulting services in Life Sciences with a focus on enabling tools and In-Vitro Diagnostics. Previously, Stephane has demonstrated leadership as Chief Executive Officer at MIP Discovery and held various senior roles, including Chief Commercial Officer and Chief Licensing Officer at BBI Solutions. With extensive experience in management and marketing across multiple organizations in the life sciences sector, Stephane Argivier has a solid educational background, including an MIB from London Business School and a BSc in Applied Biology with a focus on Biotechnology.
This person is not in any teams
MIP Diagnostics
MIP Diagnostics Ltd was founded in 2015 as a spin out from the University of Leicester by several leading experts in the field, including Prof. Sergey Piletsky, in order to commercialise various forms of Molecularly Imprinted Polymers (MIPs), sometimes called "plastic antibodies". Their proprietary technology includes a novel method tomake nanoMIPs which circumvents the drawbacks of traditional MIP manufacturing methods. NanoMIPS are, as the name suggests, nanostructured polymer particles typically containing a single binding site for their target. Whilst MIPs are exceptionally robust polymers [plastics], nanoMIPS are sufficiently small to be essentially soluble. They can also be fused to solid substrates, such as sensor surfaces, if required. The robust nature of MIPs and nanoMIPs make them ideal reagents for a wide range of applications including point-of-care diagnostics and in field based testing.